Merck’s COVID-19 pill could carry serious safety concerns, scientists warn
Merck’s newinfectious-disease pill, known as molnupiravir, headed for FDA review for emergency authorization, could potentially carry serious safety issues stemming from the method used to kill the virus, scientists warned, according to a report. The oral antiviral medication integrates into the genetic makeup of the virus, causing a large number of mutations to destroy the…